ABBV - AbbVie Inc.
Close
192.87
0 0%
Share volume: 0
Last Updated: Fri 20 Dec 2024 09:01:36 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.46%
PREVIOUS CLOSE
CHG
CHG%
$192.87
-20.90
0.12%
Summary score
54%
Profitability
50%
Dept financing
50%
Liquidity
12%
Performance
71%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
13.79%
Return on assets
2.76%
Return on sales
28.74%
Return on invested capital
2.36%
Total debt ratio
90.46%
Debt ratio change over timeo
308.97%
Current Ratio
0.9%
Quick Ratio
0.78%
Cash Position Ratio
0.32%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
13.77%
Return on assets
2.43%
Return on sales
24.64%
Return on invested capital
2.14%
Total debt ratio
92.14%
Debt ratio change over timeo
46.38%
Current Ratio
0.91%
Quick Ratio
0.8%
Cash Position Ratio
0.36%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
16.97%
Return on assets
1.99%
Return on sales
24.06%
Return on invested capital
1.98%
Total debt ratio
94.62%
Debt ratio change over time
73.42%
Current Ratio
0.94%
Quick Ratio
0.83%
Cash Position Ratio
0.44%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
4170.35%
Return on assets
697.66%
Return on sales
8914.11%
Return on invested capital
543.81%
Total debt ratio
30896.85%
Debt ratio change over time
308.97%
Current Ratio
320.77%
Quick Ratio
273.79%
Cash Position Ratio
109.53%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABBV | AMGN | REGN | VRTX |
|---|---|---|---|---|
| Return on equity | 13.79% | 34.47% | 7.43% | 6.63% |
| Return on assets | 2.76% | 3.15% | 5.62% | 5.89% |
| Return on sales | 28.74% | 32.53% | 40.48% | 43.61% |
| Return on invested capital | 2.36% | 5.39% | 19.77% | 34.89% |
| Profitability | 40% | 61% | 67% | 80% |
| Total debt ratio | 90.46% | 90.54% | 26.74% | 24.36% |
| Debt ratio change over time | 308.97% | -6.99% | 1.18% | 0.04% |
| Dept financing | 50% | 25% | 7% | 7% |
| Current Ratio | 0.91% | 2.18% | 5.4% | 3.93% |
| Quick Ratio | 0.8% | 1.79% | 4.64% | 3.73% |
| Cash Position Ratio | 0.36% | 1.28% | 2.93% | 3.13% |
| Liquididy | 12% | 27% | 63% | 74% |
| Short-term ratios | ABBV | AMGN | REGN | VRTX |
|---|---|---|---|---|
| Return on equity | 13.77% | 13.25% | 3.8% | 5.91% |
| Return on assets | 2.43% | 1.89% | 3.09% | 4.97% |
| Return on sales | 24.64% | 23.72% | 30.49% | 43.17% |
| Return on invested capital | 2.14% | 3.39% | 9.18% | 23.7% |
| Profitability | 54% | 51% | 50% | 86% |
| Total debt ratio | 92.14% | 93.05% | 21.79% | 23.27% |
| Debt ratio change over time | 46.38% | -72.08% | 1.51% | -0.36% |
| Dept financing | 50% | 25% | 7% | 6% |
| Current Ratio | 0.91% | 2.18% | 5.4% | 3.93% |
| Quick Ratio | 0.8% | 1.79% | 4.64% | 3.73% |
| Cash Position Ratio | 0.36% | 1.28% | 2.93% | 3.13% |
| Liquididy | 11% | 30% | 73% | 63% |